Equivalent price position
Unlock the full competitive price benchmark
See the exact peer median, min/max and quartiles, product rank, price percentile and the complete like-for-like competitor table.
Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.
Product details
- Generic
- Losartan
- Therapeutic area
- Cardiovascular
- Drug class
- Angiotensin II receptor blockers
- ATC
- C09CA01
- Strength
- 50 mg
- Dosage form
- Tablet
- Pack
- 2x10's
- Registration no.
- 035650
- Price record verified
- 2026-08-08
- Latest DRAP source check
- 2026-10-10 03:32
Manufacturer
Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.
View company portfolio →About Kosart 50 mg tablet
Kosart 50 mg tablet contains Losartan 50 mg. It is registered with DRAP by Pearl Pharmaceuticals (registration no. 035650). Its official price is PKR 380.12 for a pack of 2x10's, about PKR 19.01 per tablet. This price has applied since 4 September 2025. Kosart is also available as 50 mg + 120 mg tablet. 68 other brands of Losartan 50 mg (tablet) are registered in Pakistan. Compare all brands and prices →
Other strengths of Kosart
Other brands of Losartan 50 mg
Official price over time
No change in the official DRAP price is recorded for this pack (2x10's). Current price PKR 380.12, effective 4 Sep 2025.
Cite this price history
MedInfoBase. Kosart 50 mg, 2x10's: official price history (source: DRAP PharmaPrice Index). https://medinfobase.com/brand/kosart-50-mg-035650-2x10s-pearl-pharmaceuticals/ (accessed 10 October 2026).
Official price history
| Amount | Effective from | Verified | Source | Status |
|---|---|---|---|---|
| PKR 380.12 | 2025-09-04 | 2026-08-08 | DRAP PharmaPrice Index | Current |
Other listed brands
Cite this record
Medicine record · DRAP registration 035650Price and registration data on this page were observed on 8 August 2026. Records change over time, so please cite the observation date alongside the access date.
